Information

  • 2020.09.29
    • NEW
      "Guideline for MM V" is published.
  • 2020.09.23
  • 2020.09.16
    • "Myeloma Web Seminar 2020: Basic and Up-to Date of diagnosis of Myeloma" will be held.
  • 2020.06.10
    • President of JSM is changed.
      Masahiro Abe appointed as new president and Chiaki Nakaseko appointed as vice president.
    • Election of Executive Directors
      New Directors: Toshiki Ito, Shuji Ozawa, Junya Kuroda
  • 2020.04.28
  • 2019.01.10
    • Nihon Kotsuzuishu Kanjanokai
      2019 Aid and support for the research project on multiple myeloma. (In Japanese)

      http://myeloma.gr.jp/for_cure/2019/01/new2019.html
      Application documents can be downloaded from this URL.
      The application (in Japanese) deadline is February 28, 2019.

      Contact information
      Nihon Kotsuzuishu Kanjanokai
      E-mail: info@myeloma.gr.jp
  • 2018.11.07
    • The 44th JSM Annual Meeting (JSM 2019)
      Abstract submission periond is decided.

      ■Abstract Submission Period:
      December 3, 2018 - January 17, 2019

      ■Abstract Submission URL:
      https://site2.convention.co.jp/44jsm/index.html

      ■Meeting dates: May 11-12, 2019

      ■Venue: WINC AICHI
      4-4-38 Meieki, Nakamura-ku, Nagoya
      450-0002, Aichi Prefecture

      ■Chairperson and Affiliation:
      Dr. Shinsuke Iida
      (Nagoya City University Graduate School of Medical Sciences Department of Hematology and Oncology)
  • 2018.10.17
    • The 44th Annual Meeting of the Japanese Society of Myeloma (JSM 2019) website opened
      -> Here
  • 2018.10.15
    • International Journal of Myeloma was issued.
      -> Here
  • 2018.07.25
    • The 44th Annual Meeting of the Japanese Society of Myeloma (JSM 2019) website opened -> Here
  • 2018.07.10
      1. Information About JSM was updated. -> Here
      2. Information about History and Chronology was updated. -> Here
      3. Information about Meetings was updated.
        -> Here
      4. Information about JSM Research Award was updated. -> Here
      5. Information about Related Links was updated.
        -> Here
  • 2018.07.02
    • International Journal of Myeloma 2018,8 (2) was issued.
      (Proceeding of 43th Annual meeting) -> Here
  • 2018.04.20
    • International Journal of Myeloma 2018,8 (1) was issued.

      Development of unexpected severe thrombocytopenia just after initiating lenalidomide: possible involvement of an immunologic mechanism -> Here
  • 2018.03.09
    • Anti-Cancer Treatment Japan will be held.

      Date: 18th May – 20th May, 2018
      Venue: Toshi Center Hotel Tokyo
      President: Kiyohiko Hatake
      URL: http://actj.umin.jp
  • 2018.01.19
  • 2018.01.10
    • The 43rd JSM Annual Meeting
      Abstract submission period was extended to January 19th.

      Submission Period:
        December 1, 2017 - January 19, 2018
  • 2017.12.01
  • 2017.11.07
    • 2018 Horinouchi Akira memorial research award
      Aid and support for the research project on myeloma. (In Japanese)

      http://myeloma.gr.jp/for_cure/2017/11/2018.html

      Application documents can be downloaded from this URL. The application (in Japanese) deadline is January 8, 2018.

      Contact information
      Nihon Kotsuzuishu Kanjanokai
      PIC: Mr. Hiroyuki Hama
      hama@lns.tohoku.ac.jp
      022-743-3432
  • 2017.11.07
    • The 44th Annual Meeting of the Japanese Society of Myeloma (JSM 2019) will be held.

      Chairperson and Affiliation:
      Dr. Shinsuke Iida
      (Nagoya City University Graduate School of Medical Sciences Department of Hematology and Oncology)

      Meeting dates: 11-12 May, 2019

      Venue: WINC AICHI
      4-4-38 Meieki, Nakamura-ku, Nagoya
      450-0002, Aichi Prefecture
  • 2017.09.11
    • The 43rd Annual Meeting of the Japanese Society of Myeloma (JSM 2018) website opened -> Here
  • 2017.10.19
    • English Website is now available.

Secretariat

Chief of Secretariat

Hiroshi Handa

Location

Department of Hematology,
Gunma University Graduate School of Medicine,
3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan
FAX:+81-27-220-8173